Browsing Tag
CNS cancer
3 posts
What manufacturing scale-up means for REYOBIQ’s regulatory and clinical trajectory
Explore how Plus Therapeutics Inc. is scaling REYOBIQ manufacturing and what it means for regulatory approval and clinical success.
Can Moleculin Biotech, Inc. translate preclinical pancreatic cancer signals into clinical impact?
Explore how Plus Therapeutics Inc. is scaling REYOBIQ manufacturing and what it means for regulatory approval and clinical success.
Plus Therapeutics wins major reimbursement milestone as Humana approves CNSide cerebrospinal fluid assay
Find out how Plus Therapeutics secured Humana’s national coverage for the CNSide assay and what it means for metastatic CNS cancer care today.